News from the Philadelphia-area life sciences industry this week includes a biopharmaceutical firm seeking greater shareholder approval for its proposed merger, a medical device developer signing a debt financing agreement for up to $60 million, and a pediatric care provider receiving over $10 million for rare disease research.